Cardiovascular Disease

Cardiovascular disease involves the heart and vessels and is the number one killer in the U.S. accounting for nearly 30-percent of all deaths. Cardiovascular disease has a number of forms but the most common are myocardial infarction and angina pectoris which affect the heart itself.

What is Cardiovascular Disease?

Diseases of disorders of this system are termed cardiovascular diseases. Cardiovascular diseases kill an estimated 17 million people worldwide each year. Majority of these are due to heart attacks and strokes.

What is Microvascular Endothelial Dysfunction?

Cardiovascular Drugs

Cardiovascular Benefits of Blueberries

Non-Communicable Diseases

Cardiovascular Disease Diagnosis

Cardiovascular Disease Research

Lowering Risk for Cardiovascular Disease

Causes and Symptoms of Hypoplastic Left Heart Syndrome

Latest Cardiovascular Disease News and Research

Research reveals widespread cardiac harm from COVID, offers solutions

Millions of people around the world are suffering with the serious cardiovascular effects of Covid infection and long Covid. A lack of clear guidance on how to reduce this suffering and prevent further harm means that patients are not receiving the care they need, and some are turning to unproven or unsafe treatments.

18 Sep 2025

Implantable device helps stabilize blood pressure in spinal cord injury patients

Getting out of bed in the morning without the risk of passing out is a game-changer for 32-year-old Cody Krebs.

17 Sep 2025

Covid vaccinations remain vital to protect global heart health

Regular Covid vaccinations should continue worldwide to reduce cardiac risks associated with the virus - according to new research from the University of East Anglia.

17 Sep 2025

Psoriasis linked to higher risk of age-related macular degeneration

New research presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2025 reveals that people with psoriasis face a significantly increased risk of developing age-related macular degeneration (AMD), a leading cause of vision loss.

17 Sep 2025

GLP-1RAs linked to lower risk of mortality and cardiovascular events in psoriasis patients

Psoriasis patients treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) face a 78% lower risk of death and a 44% lower risk of major cardiovascular events compared to those taking other diabetes or weight-loss medications, new research has shown.

17 Sep 2025

Cocoa extract supplements linked to reduced inflammation in older adults

Could cocoa extract supplements rich in cocoa flavanols reduce inflammation and, in turn, prevent age-related chronic diseases? In a new study from the COcoa Supplement and Multivitamin Outcomes Study (COSMOS), investigators from Mass General Brigham and their colleagues looked at changes in five age-related markers of inflammation among participants who received daily cocoa supplements over several years.

17 Sep 2025

New AI-driven algorithm can accurately predict nearly 70% of hot flashes

University of Massachusetts Amherst researchers and scientists at Embr Labs, a Boston-based start-up, have developed an AI-driven algorithm that can accurately predict nearly 70% of hot flashes before they're perceived.

17 Sep 2025

Watching more than 4 hours of TV daily raises the risk of cognitive decline

This study finds a link between long TV viewing and cognitive impairment, stressing the importance of addressing sedentary lifestyles for dementia prevention.

17 Sep 2025

Exercise found to reduce artery hardening after weight loss in adults with obesity

Maintaining weight loss with regular exercise rather than the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide, a drug used to treat type 2 diabetes and obesity, seems to reduce atherosclerosis development in adults with obesity-a leading underlying cause of cardiovascular disease.

17 Sep 2025

Deep learning algorithm uses mammograms and age for heart disease prediction

A new machine learning model developed by The George Institute for Global Health can successfully predict heart disease risk in women by analyzing mammograms. The findings were published today in Heart, the official journal of the British Cardiovascular Society.

17 Sep 2025

Lifestyle changes show promise in preventing cognitive decline and Alzheimer’s disease

An estimated 7.2 million Americans over age 65 currently live with Alzheimer's disease (AD). That number is expected to nearly double to 13.8 million by 2060.

16 Sep 2025

Daily meal timing influences longevity risk in adults, study reveals

Researchers analysing Aging Cell data from over 33,000 US adults found a U-shaped link between daily eating window length and mortality. Eating for 11–12 hours per day was tied to the lowest risk, while very short (<8h) or long (≥15h) windows raised death risk, especially in older and White participants.

15 Sep 2025

Target: BP™ initiative works relentlessly to help people with hypertension

Nearly half of U.S. adults - 122.4 million people - are living with high blood pressure (BP), a leading preventable risk factor for heart disease, stroke and premature death, according to the 2025 American Heart Association Statistical Update.

15 Sep 2025

New initiative aims to elevate the standard of care and improve outcomes for people with heart failure

The American Heart Association, a relentless force changing the future of health for everyone everywhere, is launching a new initiative to improve in-hospital care for people with heart failure with preserved ejection fraction (HFpEF) and heart failure with mildly reduced ejection fraction (HFmrEF).

15 Sep 2025

Study warns women with type 2 diabetes against using oral estrogen therapy

In women with type 2 diabetes (T2D), use of hormone replacement therapy (HRT) skin patches is not associated with a higher risk of blood clots or stroke.

15 Sep 2025

Cannabis use may quadruple the risk of developing diabetes

Cannabis use is linked to an almost quadrupling in the risk of developing diabetes, according to an analysis of real-world data from over 4 million adults, being presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 Sept).

15 Sep 2025

Study: Half of adults without diabetes taking weight-loss drug discontinue treatment within a year

The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at helping individuals lose weight.

15 Sep 2025

How processed red meat might drive neurodegenerative diseases

The relationship between processed red meat and neurodegenerative diseases is complex, with potential risks and protective effects requiring more investigation.

15 Sep 2025

Genetic study shows dual GIPR/GLP1R action curbs binge alcohol use

Researchers used drug-target Mendelian randomization to test whether genetically proxied activation of GLP1R and GIPR influences alcohol-related behaviors. They found that GIPR, especially when combined with GLP1R, was linked to lower binge and heavy drinking, healthier food preferences, improved liver markers, and reduced coronary artery disease risk.

15 Sep 2025

Automated AI analysis of mammogram images and age can predict cardiovascular disease risk

An AI algorithm based only on routine mammogram images plus age can predict a woman's risk of major cardiovascular disease as well as standard risk assessment methods, finds research published online in the journal Heart.

13 Sep 2025